Research Nester published a report titled “AI-based Clinical Trials Solution Providers Market: Global Demand Analysis & Opportunity Outlook 2031” which delivers a detailed overview of the global AI-based clinical trials solution providers market in terms of market segmentation by application, clinical trial phase, end user and by region.
There are many interesting and amazing details about animals that you may not have known. For example, can cats eat tomatoes Whether you’re interested in animals as pets, food sources, or natural history, you’ll find the information you need on About Animals.
Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends associated with the market’s growth.
The global AI-based clinical trials solution providers market is anticipated to grow by a CAGR of ~22% over the forecast period, i.e., 2022 – 2031. The market is segmented by application into oncology, cardiovascular diseases, metabolic diseases, neurological diseases and others. Out of these,the oncology segment is anticipated to garner the largest revenueand further grow significantly in the coming years. Factors such as theincreasing prevalence of cancer and the rising number of drug trialssupport the growth of the segment market.
The global AI-based clinical trials solution providers market is estimated to garner significant revenue during the forecasted period on account ofthe increasing initiatives by various government and private organizations for therapeutic areas for clinical trials and increasing prevalence of cancer.
The global AI-based clinical trials solutions providers market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. Out of these, the North American region is projected to grow at the highest CAGR throughout the forecast period. This can be attributed to the increasing number of regional AI-based startups. Additionally, increasing awareness of AI-based clinical trials supports market growth in the North American region.
The research is global and covers a detailed analysis of the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of the Middle East and Africa). In addition, the research report covered and displayed the analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook, etc.
Growing Number of Cancer Patients to Drive Market Growth
According to the World Health Organization, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or almost one in six. Breast, lung, colon, rectum, and prostate are the most common type of cancer. In addition, every year, approximately 400,000 children develop cancer globally. Thus, the increasing prevalence of cancer raises the need for new and innovative drugs for cancer treatment which drives the market growth.
However, strict regulations, privacy-related concerns, and lack of AI implementation framework are some critical restraintstotheglobal AI-based clinical trial solution providers.
This report also provides a competitive scenario of some key players in the global AI-based clinical trial solution providers market, including Unlearn.AI, Inc., Saama Technologies, Inc., Biosymetrics, Phesi, Deep6.ai, Innoplexus, Mendel.ai, Intelligencia, Median Technologies, and others. The profiling enfolds critical information, encompassing business overviews, products and services, key financials, and recent news and developments. On the whole, the report depicts a detailed overview of the global AI-based clinical trials solution providers that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players exploring possibilities, and other stakeholders to align their market-centric strategies according to the ongoing and expected trends in the future.